blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP1166792

EP1166792 - Extracts, compounds & pharmaceutical compositions having anti-diabetic activity and their use [Right-click to bookmark this link]
StatusPatent revoked
Status updated on  02.12.2011
Database last updated on 25.09.2024
Most recent event   Tooltip17.04.2015Change - lapse in a contracting state
New state(s): CY, TR		published on 20.05.2015  [2015/21]
Applicant(s)For all designated states
PHYTOPHARM PLC
Corpus Christi House, 9 West Street Godmanchester
Cambridgeshire PE18 8HG / GB
[2009/18]
Former [2008/32]For:AT  BE  CH  DE  DK  ES  FI  FR  GR  IT  LI  LU  MC  NL  PT  SE  TR 
UNILEVER N.V.
Weena 455
3013 AL Rotterdam / NL
For:CY  GB  IE 
Unilever PLC
Unilever House Blackfriars London
EC4P 4BQ / GB
Former [2008/19]For:AT  BE  CH  DE  DK  ES  FI  FR  GR  IT  LI  LU  MC  NL  PT  SE  TR 
UNILEVER N.V.
Weena 455
3013 AL Rotterdam / NL
For:CY  GB  IE 
Unilever PLC
Unilever House Blackfriars
London EC4P 4BQ / GB
Former [2006/19]For all designated states
UNILEVER N.V.
Weena 455
3013 AL Rotterdam / NL
Former [2002/01]For all designated states
PHYTOPHARM PLC
Corpus Christi House, 9 West Street
Godmanchester, Cambridgeshire PE18 8HG / GB
Inventor(s)01 / Rubin, Ian Duncan
11 Lucknow Drive
Nottingham NG3 5EU / GB
02 / Cawthorne, Michael Anthony, The Core Laboratory
for Life Sciences, University of Buckingham
Milton Keynes MK18 1EG / GB
03 / Bindra, Jasjit Singh
171 Neptune Drive
Groton, Connecticut, CN 06340 / US
 [2002/01]
Representative(s)Brown, David Leslie, et al
Haseltine Lake Kempner LLP
Redcliff Quay
120 Redcliff Street
Bristol BS1 6HU / GB
[N/P]
Former [2009/17]Brown, David Leslie, et al
Haseltine Lake Redcliff Quay 120 Redcliff Street
Bristol BS1 6HU / GB
Former [2008/19]Wurfbain, Gilles L.
Unilever Patent Group Olivier van Noortlaan 120
3133 AT Vlaardingen / NL
Former [2004/48]Brown, David Leslie
HASELTINE LAKE, Redcliff Quay 120 Redcliff Street
Bristol BS1 6HU / GB
Former [2002/01]Silverman, Warren
Haseltine Lake & Co. Imperial House, 15-19 Kingsway
London WC2B 6UD / GB
Application number, filing date01305172.714.06.2001
[2002/01]
Priority number, dateGB2000001621330.06.2000         Original published format: GB 0016213
[2002/01]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report 
No.:EP1166792
Date:02.01.2002
Language:EN
[2002/01]
Type: A3 Search report 
No.:EP1166792
Date:05.03.2003
[2003/10]
Type: B1 Patent specification 
No.:EP1166792
Date:16.07.2008
Language:EN
[2008/29]
Search report(s)(Supplementary) European search report - dispatched on:EP22.01.2003
ClassificationIPC:A61K36/00, A61K31/58, A61K31/7034, A61P3/10
[2007/52]
CPC:
A61K45/06 (EP,US); A61K31/57 (EP,US); A61K31/58 (EP,US);
A61K31/78 (EP,US); A61K36/27 (EP,US); A61P3/10 (EP);
A61P31/10 (EP) (-)
Former IPC [2003/10]A61K35/78, A61K31/58, A61K31/7034, A61P3/10
Former IPC [2002/01]A61K35/78, A61K31/57, A61K31/58, A61K31/78, A61P3/10
Designated contracting statesAT,   BE,   CH,   CY,   DE,   DK,   ES,   FI,   FR,   GB,   GR,   IE,   IT,   LI,   LU,   MC,   NL,   PT,   SE,   TR [2002/01]
TitleGerman:Extrakte, Wirkstoffe und pharmazeutische Präparate mit antidiabetischen Eigenschaften und ihre Verwendung[2007/52]
English:Extracts, compounds & pharmaceutical compositions having anti-diabetic activity and their use[2002/01]
French:Extraits, agents et compositions pharmaceutiques à activité antidiabétique et leur utilisation[2002/01]
Former [2002/01]Extrakten, Wirkstoffe und pharmazeutische Präparate mit antidiabetischen Eigenschaften und ihre Verwendung
Examination procedure26.02.2003Examination requested  [2003/18]
14.04.2003Despatch of a communication from the examining division (Time limit: M08)
23.12.2003Reply to a communication from the examining division
10.11.2004Despatch of a communication from the examining division (Time limit: M07)
05.07.2005Reply to a communication from the examining division
26.11.2007Cancellation of oral proceeding that was planned for 29.01.2008
26.11.2007Minutes of oral proceedings despatched
29.01.2008Date of oral proceedings
29.01.2008Date of oral proceedings (cancelled)
01.02.2008Communication of intention to grant the patent
07.05.2008Fee for grant paid
07.05.2008Fee for publishing/printing paid
Opposition(s)Opponent(s)01  14.04.2009    ADMISSIBLE
Working Group of Indigenous Minorities in Southern Africa, (WIMSA)
8 Bach Street Erklärung von Bern Dienerstrasse 12, CH-8026 Zürich (Schweiz)
Windhoek / NA
Opponent's representative
Dolder, Fritz, et al, et al
Rosenbergstrasse 6 Postfach 558
8304 Wallisellen-Zürich / CH
 [N/P]
Former [2009/21]
Opponent(s)01  14.04.2009    ADMISSIBLE
Working Group of Indigenous Minorities in Southern Africa, (WIMSA)
Welfare Organisation, Section 19 of Act 12 of 1979 (Reg. No. WO 136) 8 Bach Street Erklärung von Bern Dienerstrasse 12, CH-8026 Zürich (Schweiz)
Windhoek / NA
Opponent's representative
Dolder, Fritz, et al, et al
Rosenbergstrasse 6 Postfach 558
8304 Wallisellen-Zürich / CH
27.05.2009Invitation to proprietor to file observations on the notice of opposition
05.02.2010Reply of patent proprietor to notice(s) of opposition
11.02.2010Communication of observations of patent proprietor (Time limit: M03)
11.05.2010Reply of parties involved to observations of patent proprietor
16.08.2011Cancellation of oral proceeding that was planned for 21.11.2011
19.08.2011Despatch of communication that the patent will be revoked
29.08.2011Legal effect of revocation of patent [2012/01]
21.11.2011Date of oral proceedings
Request for further processing for:05.07.2005Request for further processing filed
14.07.2005Full payment received (date of receipt of payment)
Request granted
26.07.2005Decision despatched
Fees paidRenewal fee
25.06.2003Renewal fee patent year 03
23.06.2004Renewal fee patent year 04
29.06.2005Renewal fee patent year 05
28.06.2006Renewal fee patent year 06
27.06.2007Renewal fee patent year 07
27.03.2008Renewal fee patent year 08
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipAT16.07.2008
BE16.07.2008
CY16.07.2008
DK16.07.2008
FI16.07.2008
IT16.07.2008
TR16.07.2008
SE16.10.2008
GR17.10.2008
ES27.10.2008
PT16.12.2008
IE14.06.2009
LU14.06.2009
CH30.06.2009
LI30.06.2009
MC30.06.2009
[2015/21]
Former [2011/21]AT16.07.2008
BE16.07.2008
DK16.07.2008
FI16.07.2008
IT16.07.2008
SE16.10.2008
GR17.10.2008
ES27.10.2008
PT16.12.2008
IE14.06.2009
LU14.06.2009
CH30.06.2009
LI30.06.2009
MC30.06.2009
Former [2010/47]AT16.07.2008
BE16.07.2008
DK16.07.2008
FI16.07.2008
IT16.07.2008
SE16.10.2008
GR17.10.2008
ES27.10.2008
PT16.12.2008
IE14.06.2009
CH30.06.2009
LI30.06.2009
MC30.06.2009
Former [2010/21]AT16.07.2008
BE16.07.2008
DK16.07.2008
FI16.07.2008
IT16.07.2008
SE16.10.2008
ES27.10.2008
PT16.12.2008
IE14.06.2009
CH30.06.2009
LI30.06.2009
MC30.06.2009
Former [2010/09]AT16.07.2008
BE16.07.2008
DK16.07.2008
FI16.07.2008
IT16.07.2008
SE16.10.2008
ES27.10.2008
PT16.12.2008
MC30.06.2009
Former [2010/07]AT16.07.2008
BE16.07.2008
DK16.07.2008
FI16.07.2008
IT16.07.2008
ES27.10.2008
PT16.12.2008
MC30.06.2009
Former [2009/39]AT16.07.2008
BE16.07.2008
DK16.07.2008
FI16.07.2008
IT16.07.2008
ES27.10.2008
PT16.12.2008
Former [2009/19]AT16.07.2008
BE16.07.2008
DK16.07.2008
FI16.07.2008
ES27.10.2008
PT16.12.2008
Former [2009/15]AT16.07.2008
FI16.07.2008
ES27.10.2008
PT16.12.2008
Former [2009/12]FI16.07.2008
ES27.10.2008
PT16.12.2008
Former [2009/09]ES27.10.2008
PT16.12.2008
Documents cited:Search[A]US4652553  (HAGMANN WILLIAM K [US], et al) [A] 1-29 * abstract *;
 [A]US5175154  (SCHWARTZ ARTHUR G [US], et al) [A] 1-29* abstract *;
 [DX]WO9846243  (CSIR [ZA], et al) [DX] 12-15,19-21,23,24 * abstract *;
 [A]FR2771105  (VITASTEROL [FR]) [A] 1-29 * abstract *;
 [PX]EP1099444  (PHYTOPHARM PLC [GB]) [PX] 12,13,19,20 * abstract *
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.